SAMD9 anticorps (Cy5)
Aperçu rapide pour SAMD9 anticorps (Cy5) (ABIN1418136)
Antigène
Voir toutes SAMD9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human SAMD9
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IF(IHC-P) 1:50-200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- SAMD9 (Sterile alpha Motif Domain Containing 9 (SAMD9))
-
Autre désignation
- SAMD9
-
Sujet
-
Synonyms: SAM domain-containing protein 9, SAMD9, SAMD9_HUMAN, sterile alpha mot domain containing 9, Sterile alpha mot domain-containing protein 9, C7orf5.
Background: Defects in SAMD9 are the cause of normophosphatemic familial tumoral calcinosis (NFTC). NFTC is an uncommon life-threatening disorder characterized by massive periarticular, and seldom visceral, deposition of calcified tumors.
-
ID gène
- 54809
Antigène
-